Emons G - Search Results

1

Emons G, Gründker C, Hanf V. Emons G, et al. Zentralbl Gynakol. 2002 Dec;124(12):559-65. doi: 10.1055/s-2002-40168. Zentralbl Gynakol. 2002. PMID: 12822069 Review. German.

2

Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.

Gründker C, Völker P, Schulz KD, Emons G. Gründker C, et al. Among authors: emons g. Gynecol Oncol. 2000 Aug;78(2):194-202. doi: 10.1006/gyno.2000.5863. Gynecol Oncol. 2000. PMID: 10926802

3

GnRH antagonists in the treatment of gynecological and breast cancers.

Emons G, Gründker C, Günthert AR, Westphalen S, Kavanagh J, Verschraegen C. Emons G, et al. Endocr Relat Cancer. 2003 Jun;10(2):291-9. doi: 10.1677/erc.0.0100291. Endocr Relat Cancer. 2003. PMID: 12790790 Review.

4

LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer.

Emons G, Weiss S, Ortmann O, Gründker C, Schulz KD. Emons G, et al. Eur J Endocrinol. 2000 Jun;142(6):665-70. doi: 10.1530/eje.0.1420665. Eur J Endocrinol. 2000. PMID: 10832105

5

Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells.

Gründker C, Schulz K, Günthert AR, Emons G. Gründker C, et al. Among authors: emons g. J Clin Endocrinol Metab. 2000 Oct;85(10):3815-20. doi: 10.1210/jcem.85.10.6859. J Clin Endocrinol Metab. 2000. PMID: 11061544

6

Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.

Gründker C, Völker P, Emons G. Gründker C, et al. Among authors: emons g. Endocrinology. 2001 Jun;142(6):2369-80. doi: 10.1210/endo.142.6.8190. Endocrinology. 2001. PMID: 11356684

7

Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin.

Gründker C, Schlotawa L, Viereck V, Emons G. Gründker C, et al. Among authors: emons g. Eur J Endocrinol. 2001 Nov;145(5):651-8. doi: 10.1530/eje.0.1450651. Eur J Endocrinol. 2001. PMID: 11720885

8

Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.

Westphalen S, Kotulla G, Kaiser F, Krauss W, Werning G, Elsasser HP, Nagy A, Schulz KD, Grundker C, Schally AV, Emons G. Westphalen S, et al. Among authors: emons g. Int J Oncol. 2000 Nov;17(5):1063-9. doi: 10.3892/ijo.17.5.1063. Int J Oncol. 2000. PMID: 11029513

9

Endometrial cancer.

Hanf V, Günthert AR, Emons G. Hanf V, et al. Among authors: emons g. Onkologie. 2003 Oct;26(5):429-36. doi: 10.1159/000072975. Onkologie. 2003. PMID: 14605458 Review.

10

[Endometrial cancer -- suggestions for the update of the guidelines].

Emons G. Emons G. Zentralbl Gynakol. 2006 Feb;128(1):18-22. doi: 10.1055/s-2006-921361. Zentralbl Gynakol. 2006. PMID: 16450282 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page